Funded Grants

PI Name Sort ascending PI Organization Title Grant Number Initiative Program Official
Zeng, Melody Yue

Weill Medical Coll Of Cornell Univ
United States

Dissecting the interplay between immunoglobulin G and the gut microbiome in cancer progression and metastasis 5R21CA270998-02
Zarrinpar, Amir

University Of California, San Diego
United States

Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer 5U01CA265719-03
Yuan, Ying

University Of Tx Md Anderson Can Ctr
United States

Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions 5U24CA274212-02 RFA-CA-21-055 (U24 Clinical Trial Not Allowed)
Yu, Dihua

University Of Tx Md Anderson Can Ctr
United States

Exploring novel strategies for immunoprevention of estrogen receptor negative breast cancer 5R01CA270010-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Yu, Danxia

Vanderbilt University Medical Center
United States

Gut microbiota-related mechanisms that impact colorectal cancer risk after bariatric surgery 1R01CA275864-01A1 Edward Sauter, M.D., Ph.D.
Yu, Anthony Francis

Sloan-Kettering Inst Can Research
United States

Effects of Exercise on Changes in Cardiovascular Biomarkers in Patients with Breast Cancer During Anthracycline-based Chemotherapy 5R03CA277194-02 Eileen Dimond, R.N., M.S.
Yu, Anthony Francis

Sloan-Kettering Inst Can Research
United States

Intensive Blood Pressure Control During Cardiotoxic Breast Cancer Treatment (PROTECT) Trial 1R37CA273923-01A1 Eileen Dimond, R.N., M.S.
You, Ming

Methodist Hospital Research Institute
United States

Inhibition of Oral Tumorigenesis by Antitumor B 7R01CA205633-06 Eva Szabo, M.D.
You, Ming

Methodist Hospital Research Institute
United States

Chemoprevention of lung cancer by targeting lonidamine to mitochondria 5R01CA232433-05
You, Ming

Methodist Hospital Research Institute
United States

Transfer Application - R01 CA223804 - Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer 5R01CA223804-05